Back to 
HighTower Advisors, LLC
HighTower Advisors, LLC
SRNE
Showing 0 of 14 quarters
Position history for HighTower Advisors, LLC's holdings in SORRENTO THERAPEUTICS INC
As of its Q4 2022 13F, HighTower Advisors held 35,512 shares of SRNE (Sorrento Therapeutics), worth $30,000. HighTower Advisors' 13F filings listed SRNE from Q4 2019 to Q4 2022, 13 quarterly filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.